- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Bavarian Nordic
Market Cap: DKK 14.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 192.50
7D
-4.0%
1Y
25.6%
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 249.45
7D
-1.0%
1Y
-39.0%
H. Lundbeck
Market Cap: DKK 41.0b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 43.12
7D
3.7%
1Y
46.1%